Skip to main content
Jenna Rychert, PhD
Medical Director: Operational Informatics and Microbial Immunology; Exception Handling, Referral Testing, and Client Response Communications teams
Adjunct Associate Professor, University of Utah School of Medicine Education Doctorate Degree—Microbiology, Immunology, and Parasitology; Louisiana State Health Sciences Center Postdoctoral Training—HIV Immunology, Harvard Medical School/Massachusetts General Hospital Fellowship—Clinical Microbiology, Harvard Medical School/Massachusetts General Hospital Certification/Affiliations American Board of Medical Microbiology (ABMM) Laboratory Logical Observation Identifier Names and Codes (LOINC) Committee American Society of Microbiology (ASM) American Medical Informatics Association (AMIA) Research Interests Laboratory informatics Interoperability Regulatory affairs Global health Awards and Community Service Global Health Travel Award, Center for Global Health, Massachusetts General Hospital, 2012 and 2014 Medical Mission Member, Wide Horizons for Children, Ethiopia, 2009-2013, 2015, and 2019 Recent Publications Genzen JR, Rychert J, George TI. Integrity of SARS-CoV-2 laboratory-developed tests . JAMA . 2022;328(5):478. Slev P, et al. 11.29 Serologic tests for diagnosis of Histoplasma capsulatum , 11.29.3 Histoplasma capsulatum antibody detection by immunodiffusion (ID). In: Leber AL, ed. Clinical Microbiology Procedures Handbook . 4th ed. ASM Press; 2016. Rychert J, Couturier MR, Elgort M, et al. Evaluation of 3 SARS-CoV-2 IgG antibody assays and correlation with neutralizing antibodies. J Appl Lab Med. 2021;6(3):614-624. Rychert J, Delgado JC, Genzen JR. Modification of in vitro diagnostic devices: leveling the playing field . Clin Chem. 2020;66(6):760-762.